🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Semaglutide and exercise performance — VO2max and endurance data Page 5

Semaglutide and exercise performance — VO2max and endurance data

RunnerRach Sun, Apr 5, 2026 at 11:50 AM 23 replies 717 viewsPage 5 of 5
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Apr 25, 2026 at 12:35 PM#21

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Apr 25, 2026 at 1:35 PM
36 9mona_PHX, andrew_nyc, Dr.EndoEP and 33 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
May 3, 2026 at 7:25 AM#22
Dr.ReproEndo said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This matches mine closely enough to be worth saying so out loud.

37 10DoseLogDan, SleepFixSam, PurityPaulOR and 34 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
May 11, 2026 at 2:10 AM#23
Dr.ReproEndo said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Coming at Dr.ReproEndo’s question from a different direction. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

38 11Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 35 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 18, 2026 at 8:51 PM#24

One concrete data point for the thread. Worth knowing that the injection site changes very little. Abdomen, thigh and upper arm are bioequivalent for semaglutide, so a site change is not a plausible explanation for a bad week.

39 12amsterdam_pete, LondonLisa, mike_nyc and 36 others
Reply Quote Save Share Report
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
May 26, 2026 at 3:27 PM#25

Following on from Dr.ReproEndo — and this may be the naive question:

Whether anyone has held at a sub-maximal dose long term and kept the result, or whether the maintenance data only exists at 2.4mg?

40 13lori_vegas, Dr.PulmRoch, maya_sedona and 37 others
Reply Quote Save Share Report
1345

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register